Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease

被引:76
作者
Brownell, AL
Jenkins, BG
Elmaleh, DR
Deacon, TW
Spealman, RD
Isacson, O [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02114 USA
[4] McLean Hosp, Neuroregenerat Labs, Belmont, MA 02178 USA
[5] New England Reg Primate Res Ctr, Southborough, MA 01772 USA
关键词
D O I
10.1038/3300
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We used brain imaging to study long-term neurodegenerative and bioadaptive neurochemical changes in a primate model of Parkinson disease. We gradually induced a selective loss of nigrostriatal dopamine neurons, similar to that of Parkinson disease, by creating oxidative stress through infusion of the mitochondrial complex 1 inhibitor MPTP for 14 +/- 5 months. Repeated evaluations over 3 years by positron emission tomography (PET) demonstrated progressive and persistent loss of neuronal dopamine pre-synaptic re-uptake sites; repeated magnetic resonance spectroscopy (MRS) studies indicated a 23-fold increase in lactate and macromolecules in the striatum region of the brain for up to 10 months after the last administration of MPTP. By 2 years after the MPTP infusions, these MRS striatal lactate and macromolecule values had returned to normal levels. In contrast, there were persistent increases in striatal choline and decreases in N-acetylaspartate. Thus, these combined PET/MRS studies demonstrate patterns of neurochemical changes that are both dynamic and persistent long after selective dopaminergic degeneration.
引用
收藏
页码:1308 / 1312
页数:5
相关论文
共 47 条
  • [1] METABOLISM OF HUMAN GLIOMAS - ASSESSMENT WITH H-1 MR SPECTROSCOPY AND F-18 FLUORODEOXYGLUCOSE PET
    ALGER, JR
    FRANK, JA
    BIZZI, A
    FULHAM, MJ
    DESOUZA, BX
    DUHANEY, MO
    INSCOE, SW
    BLACK, JL
    VANZIJL, PCM
    MOONEN, CTW
    DICHIRO, G
    [J]. RADIOLOGY, 1990, 177 (03) : 633 - 641
  • [2] USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS
    ARNOLD, DL
    RIESS, GT
    MATTHEWS, PM
    FRANCIS, GS
    COLLINS, DL
    WOLFSON, C
    ANTEL, JP
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (01) : 76 - 82
  • [3] N-ACETYL-L-ASPARTIC ACID - A LITERATURE-REVIEW OF A COMPOUND PROMINENT IN H-1-NMR SPECTROSCOPIC STUDIES OF BRAIN
    BIRKEN, DL
    OLDENDORF, WH
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1989, 13 (01) : 23 - 31
  • [4] Brooks D. J., 1993, Neurology, V43, pS6
  • [5] Brownell AL, 1996, J NUCL MED, V37, P1186
  • [6] Brownell G. L., 1989, International Journal of Imaging Systems and Technology, V1, P207, DOI 10.1002/ima.1850010210
  • [7] BROWNELL GL, 1985, METABOLISM HUMAN BRA, P13
  • [8] LOSS OF STRIATAL NEURONS IN PARKINSONS-DISEASE - A CYTOMETRIC STUDY
    BUGIANI, O
    PERDELLI, F
    SALVARANI, S
    LEONARDI, A
    MANCARDI, GL
    [J]. EUROPEAN NEUROLOGY, 1980, 19 (05) : 339 - 344
  • [9] A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    BURNS, RS
    CHIUEH, CC
    MARKEY, SP
    EBERT, MH
    JACOBOWITZ, DM
    KOPIN, IJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14): : 4546 - 4550
  • [10] CALNE DDB, 1985, NATURE, V317, P244